Below is a clip from Andrew Satz’s (CEO, EVQLV) speech at the Flatiron School. He explains what we do at EVQLV and how we do it.
In short, we use artificial intelligence (AI) to discover and optimize novel biologics. Our algorithm uses an evolutionary approach with applied external pressures to generate candidates. There’s a lot more to it, but we thought you might enjoy a taste of our “secret sauce.”
If you’d like to learn more about EVQLV and our work, feel free to contact us.